The WHO Working Group on Drug Financing of the Regional Office for South-East Asia and the Action Programme on Essential Drugs would like to thank G. Grayston and J. Sawyer for their editorial contribution and M. Clarke and K. O'Leary for their assistance with the layout of this document.
© World Health Organization 1998
This document is not issued to the general public, and all rights are reserved by the World Health Organization (WHO). The document may not be reviewed, abstracted, quoted, reproduced or translated, in part or in whole, without the prior written permission of WHO. No part of this document may be stored in a retrieval system or transmitted in any form or by any means - electronic, mechanical or other - without the prior permission of WHO.
The views expressed in documents by named authors are solely the responsibility of those authors.